Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Commercial Officer
-
Stock Symbol
-
KNSA on Nasdaq
Ross Moat - trading volume in the past year for Kiniksa Pharmaceuticals International, plc
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Class A Ordinary Share |
21.7K |
$589K |
$27.12 |
Sep 3, 2024 |
Direct |
|
|
Class A Common Share |
16.3K |
$291K |
$17.90 |
Apr 8, 2024 |
Direct |
|
|
Performance Share Unit |
5.57K |
$99.7K |
$17.90 |
Apr 4, 2024 |
Direct |
Class A Common Share |
|
Share Option |
30.9K |
|
|
Sep 3, 2024 |
Direct |
Class A Ordinary Share |
|
Restricted Share Unit |
9.32K |
|
|
Apr 8, 2024 |
Direct |
Class A Common Share |
|
Restricted Share Unit |
994 |
|
|
Sep 2, 2024 |
Direct |
Class A Ordinary Share |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.